Pfizer COVID-19 Vaccine Makes It First To Finish Line; United Kingdom Authorizes Today & Rollout Begins Next Week 02/12/2020 Elaine Ruth Fletcher Pfizer’s COVID-19 vaccine, a cutting edge mRNA technology produced jointly with the German firm BioNTech, was authorized for use on Wednesday by the United Kingdom – making it the vaccine the first to be rolled out for commercial public use as early as next week. The vaccine was authorised Wednesday morning for emergency use by […] Continue reading -> COVID Vaccine Fever: Moderna Announces US FDA and European Medicines Agency Submissions; Pfizer and AstraZeneca First In Line For UK Approvals 30/11/2020 Elaine Ruth Fletcher Moderna on Monday announced that it would immediately request emergency authorization today for its mRNA COVID-19 vaccine candidate from both the U.S. Food and Drug Administration (US FDA) and the European Medicines Agency – as well as asking the World Health Organization for an emergency use listing. The announcement came in a week that will […] Continue reading -> WHO Experts Investigating Mysterious Origins Of SARS-CoV2 Virus ‘Will’ Visit Wuhan, China – But No Date Set 27/11/2020 Elaine Ruth Fletcher In a politically charged series of exchanges at a Friday press briefing, World Health Organization officials pushed back against queries by a representative of China’s state-controlled CCTV, asking about whether the SARS-CoV2 virus discovered in Wuhan, China in December of 2019 could have been circulating in humans “outside of China before the outbreak in Wuhan, […] Continue reading -> AstraZeneca Vaccine Most Attractive Option For Africa, Says WHO – Astra Zeneca CEO Says Company Will Run New Trial To Test More Efficient Dose 26/11/2020 Maina Waruru & Elaine Ruth Fletcher Nairobi. Africa’s limited cold-chain capacity will constrain the continent’s ability to take up the more cutting-edge Pfizer and Moderna vaccines that are likely to win approval first from regulatory authorities, said WHO’s African Regional Director Dr Matshidiso Moeti on Thursday. Those same constraints make the AstraZeneca (AZD1222) vaccine the most attractive option, despite its lower […] Continue reading -> Philanthropy Alone Will Not Ensure Global Access To COVID-19 Vaccines – South Africa’s Take 25/11/2020 Kerry Cullinan & Elaine Ruth Fletcher South Africa is campaigning for the World Trade Organization (WTO) to waiver intellectual property rights on all products related to COVID-19 for the duration of the pandemic. Mustaqeem De Gama, Counsellor at the South African Permanent Mission in Geneva, is leading the campaign. Kerry Cullinan and Elaine Fletcher spoke to him about the reasons why […] Continue reading -> Major New Clinical Trial Launched Across 13 African Countries To Test Treatments For Mild COVID-19 Cases 24/11/2020 Elaine Ruth Fletcher Thirteen African countries and an international network of research institutions have joined forces to launch a multi-country clinical trial of COVID-19 drug treatments in Africa for people who are mild to moderately ill. The new ANTICOV trial, led by the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) aims to respond to the urgent need to […] Continue reading -> AstraZeneca Breakthrough Heightens Competition Between Two Different World Views On Vaccine Procurement & Distribution 23/11/2020 Elaine Ruth Fletcher, Menaka Rao & Kerry Cullinan The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading -> AstraZeneca’s COVID-19 Vaccine Candidate Can Prevent 90% Of Infections – Company Unveils Interim Results 23/11/2020 Madeleine Hoecklin & Elaine Ruth Fletcher AstraZeneca, the pharma firm developing a COVID-19 vaccine in collaboration with researchers at Oxford University, announced that its Phase 3 clinical trials had resulted in a 90% efficacy rate for one dosing regime, in interim results released on Monday. The AstraZeneca breakthrough is significant because the vaccine, based on a known vaccine delivery technology, is […] Continue reading -> Médecins Sans Frontières – Nearly 100 World Trade Organization Members Could Support “Waiver” On IP For COVID Health Technologies 19/11/2020 Elaine Ruth Fletcher Nearly 100 World Trade Organization member countries and entities could potentially swing behind a proposal by India and South Africa to enact a wide-ranging waiver of complex World Trade Organization requirements on the use of patented products, trade secrets and copyrights on health products during the pandemic, asserted the Médecins Sans Frontières (MSF) Access […] Continue reading -> Moderna’s COVID Vaccine Is 95% Effective – Independent NIH-Appointed Board Assessment – Higher Storage Temperature Make It Even Better News 16/11/2020 Elaine Ruth Fletcher Moderna’s mRNA vaccine candidate has had a vaccine efficacy of 94.5%, the company announced today. unveiling the stunning, initial analysis of Phase 3 clinical trial results by an independent Data Safety Monitoring Board, appointed by the US National Institutes of Health. And news that the vaccine can be stored at 2° to 8°C (36° to […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID Vaccine Fever: Moderna Announces US FDA and European Medicines Agency Submissions; Pfizer and AstraZeneca First In Line For UK Approvals 30/11/2020 Elaine Ruth Fletcher Moderna on Monday announced that it would immediately request emergency authorization today for its mRNA COVID-19 vaccine candidate from both the U.S. Food and Drug Administration (US FDA) and the European Medicines Agency – as well as asking the World Health Organization for an emergency use listing. The announcement came in a week that will […] Continue reading -> WHO Experts Investigating Mysterious Origins Of SARS-CoV2 Virus ‘Will’ Visit Wuhan, China – But No Date Set 27/11/2020 Elaine Ruth Fletcher In a politically charged series of exchanges at a Friday press briefing, World Health Organization officials pushed back against queries by a representative of China’s state-controlled CCTV, asking about whether the SARS-CoV2 virus discovered in Wuhan, China in December of 2019 could have been circulating in humans “outside of China before the outbreak in Wuhan, […] Continue reading -> AstraZeneca Vaccine Most Attractive Option For Africa, Says WHO – Astra Zeneca CEO Says Company Will Run New Trial To Test More Efficient Dose 26/11/2020 Maina Waruru & Elaine Ruth Fletcher Nairobi. Africa’s limited cold-chain capacity will constrain the continent’s ability to take up the more cutting-edge Pfizer and Moderna vaccines that are likely to win approval first from regulatory authorities, said WHO’s African Regional Director Dr Matshidiso Moeti on Thursday. Those same constraints make the AstraZeneca (AZD1222) vaccine the most attractive option, despite its lower […] Continue reading -> Philanthropy Alone Will Not Ensure Global Access To COVID-19 Vaccines – South Africa’s Take 25/11/2020 Kerry Cullinan & Elaine Ruth Fletcher South Africa is campaigning for the World Trade Organization (WTO) to waiver intellectual property rights on all products related to COVID-19 for the duration of the pandemic. Mustaqeem De Gama, Counsellor at the South African Permanent Mission in Geneva, is leading the campaign. Kerry Cullinan and Elaine Fletcher spoke to him about the reasons why […] Continue reading -> Major New Clinical Trial Launched Across 13 African Countries To Test Treatments For Mild COVID-19 Cases 24/11/2020 Elaine Ruth Fletcher Thirteen African countries and an international network of research institutions have joined forces to launch a multi-country clinical trial of COVID-19 drug treatments in Africa for people who are mild to moderately ill. The new ANTICOV trial, led by the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) aims to respond to the urgent need to […] Continue reading -> AstraZeneca Breakthrough Heightens Competition Between Two Different World Views On Vaccine Procurement & Distribution 23/11/2020 Elaine Ruth Fletcher, Menaka Rao & Kerry Cullinan The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading -> AstraZeneca’s COVID-19 Vaccine Candidate Can Prevent 90% Of Infections – Company Unveils Interim Results 23/11/2020 Madeleine Hoecklin & Elaine Ruth Fletcher AstraZeneca, the pharma firm developing a COVID-19 vaccine in collaboration with researchers at Oxford University, announced that its Phase 3 clinical trials had resulted in a 90% efficacy rate for one dosing regime, in interim results released on Monday. The AstraZeneca breakthrough is significant because the vaccine, based on a known vaccine delivery technology, is […] Continue reading -> Médecins Sans Frontières – Nearly 100 World Trade Organization Members Could Support “Waiver” On IP For COVID Health Technologies 19/11/2020 Elaine Ruth Fletcher Nearly 100 World Trade Organization member countries and entities could potentially swing behind a proposal by India and South Africa to enact a wide-ranging waiver of complex World Trade Organization requirements on the use of patented products, trade secrets and copyrights on health products during the pandemic, asserted the Médecins Sans Frontières (MSF) Access […] Continue reading -> Moderna’s COVID Vaccine Is 95% Effective – Independent NIH-Appointed Board Assessment – Higher Storage Temperature Make It Even Better News 16/11/2020 Elaine Ruth Fletcher Moderna’s mRNA vaccine candidate has had a vaccine efficacy of 94.5%, the company announced today. unveiling the stunning, initial analysis of Phase 3 clinical trial results by an independent Data Safety Monitoring Board, appointed by the US National Institutes of Health. And news that the vaccine can be stored at 2° to 8°C (36° to […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Experts Investigating Mysterious Origins Of SARS-CoV2 Virus ‘Will’ Visit Wuhan, China – But No Date Set 27/11/2020 Elaine Ruth Fletcher In a politically charged series of exchanges at a Friday press briefing, World Health Organization officials pushed back against queries by a representative of China’s state-controlled CCTV, asking about whether the SARS-CoV2 virus discovered in Wuhan, China in December of 2019 could have been circulating in humans “outside of China before the outbreak in Wuhan, […] Continue reading -> AstraZeneca Vaccine Most Attractive Option For Africa, Says WHO – Astra Zeneca CEO Says Company Will Run New Trial To Test More Efficient Dose 26/11/2020 Maina Waruru & Elaine Ruth Fletcher Nairobi. Africa’s limited cold-chain capacity will constrain the continent’s ability to take up the more cutting-edge Pfizer and Moderna vaccines that are likely to win approval first from regulatory authorities, said WHO’s African Regional Director Dr Matshidiso Moeti on Thursday. Those same constraints make the AstraZeneca (AZD1222) vaccine the most attractive option, despite its lower […] Continue reading -> Philanthropy Alone Will Not Ensure Global Access To COVID-19 Vaccines – South Africa’s Take 25/11/2020 Kerry Cullinan & Elaine Ruth Fletcher South Africa is campaigning for the World Trade Organization (WTO) to waiver intellectual property rights on all products related to COVID-19 for the duration of the pandemic. Mustaqeem De Gama, Counsellor at the South African Permanent Mission in Geneva, is leading the campaign. Kerry Cullinan and Elaine Fletcher spoke to him about the reasons why […] Continue reading -> Major New Clinical Trial Launched Across 13 African Countries To Test Treatments For Mild COVID-19 Cases 24/11/2020 Elaine Ruth Fletcher Thirteen African countries and an international network of research institutions have joined forces to launch a multi-country clinical trial of COVID-19 drug treatments in Africa for people who are mild to moderately ill. The new ANTICOV trial, led by the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) aims to respond to the urgent need to […] Continue reading -> AstraZeneca Breakthrough Heightens Competition Between Two Different World Views On Vaccine Procurement & Distribution 23/11/2020 Elaine Ruth Fletcher, Menaka Rao & Kerry Cullinan The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading -> AstraZeneca’s COVID-19 Vaccine Candidate Can Prevent 90% Of Infections – Company Unveils Interim Results 23/11/2020 Madeleine Hoecklin & Elaine Ruth Fletcher AstraZeneca, the pharma firm developing a COVID-19 vaccine in collaboration with researchers at Oxford University, announced that its Phase 3 clinical trials had resulted in a 90% efficacy rate for one dosing regime, in interim results released on Monday. The AstraZeneca breakthrough is significant because the vaccine, based on a known vaccine delivery technology, is […] Continue reading -> Médecins Sans Frontières – Nearly 100 World Trade Organization Members Could Support “Waiver” On IP For COVID Health Technologies 19/11/2020 Elaine Ruth Fletcher Nearly 100 World Trade Organization member countries and entities could potentially swing behind a proposal by India and South Africa to enact a wide-ranging waiver of complex World Trade Organization requirements on the use of patented products, trade secrets and copyrights on health products during the pandemic, asserted the Médecins Sans Frontières (MSF) Access […] Continue reading -> Moderna’s COVID Vaccine Is 95% Effective – Independent NIH-Appointed Board Assessment – Higher Storage Temperature Make It Even Better News 16/11/2020 Elaine Ruth Fletcher Moderna’s mRNA vaccine candidate has had a vaccine efficacy of 94.5%, the company announced today. unveiling the stunning, initial analysis of Phase 3 clinical trial results by an independent Data Safety Monitoring Board, appointed by the US National Institutes of Health. And news that the vaccine can be stored at 2° to 8°C (36° to […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
AstraZeneca Vaccine Most Attractive Option For Africa, Says WHO – Astra Zeneca CEO Says Company Will Run New Trial To Test More Efficient Dose 26/11/2020 Maina Waruru & Elaine Ruth Fletcher Nairobi. Africa’s limited cold-chain capacity will constrain the continent’s ability to take up the more cutting-edge Pfizer and Moderna vaccines that are likely to win approval first from regulatory authorities, said WHO’s African Regional Director Dr Matshidiso Moeti on Thursday. Those same constraints make the AstraZeneca (AZD1222) vaccine the most attractive option, despite its lower […] Continue reading -> Philanthropy Alone Will Not Ensure Global Access To COVID-19 Vaccines – South Africa’s Take 25/11/2020 Kerry Cullinan & Elaine Ruth Fletcher South Africa is campaigning for the World Trade Organization (WTO) to waiver intellectual property rights on all products related to COVID-19 for the duration of the pandemic. Mustaqeem De Gama, Counsellor at the South African Permanent Mission in Geneva, is leading the campaign. Kerry Cullinan and Elaine Fletcher spoke to him about the reasons why […] Continue reading -> Major New Clinical Trial Launched Across 13 African Countries To Test Treatments For Mild COVID-19 Cases 24/11/2020 Elaine Ruth Fletcher Thirteen African countries and an international network of research institutions have joined forces to launch a multi-country clinical trial of COVID-19 drug treatments in Africa for people who are mild to moderately ill. The new ANTICOV trial, led by the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) aims to respond to the urgent need to […] Continue reading -> AstraZeneca Breakthrough Heightens Competition Between Two Different World Views On Vaccine Procurement & Distribution 23/11/2020 Elaine Ruth Fletcher, Menaka Rao & Kerry Cullinan The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading -> AstraZeneca’s COVID-19 Vaccine Candidate Can Prevent 90% Of Infections – Company Unveils Interim Results 23/11/2020 Madeleine Hoecklin & Elaine Ruth Fletcher AstraZeneca, the pharma firm developing a COVID-19 vaccine in collaboration with researchers at Oxford University, announced that its Phase 3 clinical trials had resulted in a 90% efficacy rate for one dosing regime, in interim results released on Monday. The AstraZeneca breakthrough is significant because the vaccine, based on a known vaccine delivery technology, is […] Continue reading -> Médecins Sans Frontières – Nearly 100 World Trade Organization Members Could Support “Waiver” On IP For COVID Health Technologies 19/11/2020 Elaine Ruth Fletcher Nearly 100 World Trade Organization member countries and entities could potentially swing behind a proposal by India and South Africa to enact a wide-ranging waiver of complex World Trade Organization requirements on the use of patented products, trade secrets and copyrights on health products during the pandemic, asserted the Médecins Sans Frontières (MSF) Access […] Continue reading -> Moderna’s COVID Vaccine Is 95% Effective – Independent NIH-Appointed Board Assessment – Higher Storage Temperature Make It Even Better News 16/11/2020 Elaine Ruth Fletcher Moderna’s mRNA vaccine candidate has had a vaccine efficacy of 94.5%, the company announced today. unveiling the stunning, initial analysis of Phase 3 clinical trial results by an independent Data Safety Monitoring Board, appointed by the US National Institutes of Health. And news that the vaccine can be stored at 2° to 8°C (36° to […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Philanthropy Alone Will Not Ensure Global Access To COVID-19 Vaccines – South Africa’s Take 25/11/2020 Kerry Cullinan & Elaine Ruth Fletcher South Africa is campaigning for the World Trade Organization (WTO) to waiver intellectual property rights on all products related to COVID-19 for the duration of the pandemic. Mustaqeem De Gama, Counsellor at the South African Permanent Mission in Geneva, is leading the campaign. Kerry Cullinan and Elaine Fletcher spoke to him about the reasons why […] Continue reading -> Major New Clinical Trial Launched Across 13 African Countries To Test Treatments For Mild COVID-19 Cases 24/11/2020 Elaine Ruth Fletcher Thirteen African countries and an international network of research institutions have joined forces to launch a multi-country clinical trial of COVID-19 drug treatments in Africa for people who are mild to moderately ill. The new ANTICOV trial, led by the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) aims to respond to the urgent need to […] Continue reading -> AstraZeneca Breakthrough Heightens Competition Between Two Different World Views On Vaccine Procurement & Distribution 23/11/2020 Elaine Ruth Fletcher, Menaka Rao & Kerry Cullinan The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading -> AstraZeneca’s COVID-19 Vaccine Candidate Can Prevent 90% Of Infections – Company Unveils Interim Results 23/11/2020 Madeleine Hoecklin & Elaine Ruth Fletcher AstraZeneca, the pharma firm developing a COVID-19 vaccine in collaboration with researchers at Oxford University, announced that its Phase 3 clinical trials had resulted in a 90% efficacy rate for one dosing regime, in interim results released on Monday. The AstraZeneca breakthrough is significant because the vaccine, based on a known vaccine delivery technology, is […] Continue reading -> Médecins Sans Frontières – Nearly 100 World Trade Organization Members Could Support “Waiver” On IP For COVID Health Technologies 19/11/2020 Elaine Ruth Fletcher Nearly 100 World Trade Organization member countries and entities could potentially swing behind a proposal by India and South Africa to enact a wide-ranging waiver of complex World Trade Organization requirements on the use of patented products, trade secrets and copyrights on health products during the pandemic, asserted the Médecins Sans Frontières (MSF) Access […] Continue reading -> Moderna’s COVID Vaccine Is 95% Effective – Independent NIH-Appointed Board Assessment – Higher Storage Temperature Make It Even Better News 16/11/2020 Elaine Ruth Fletcher Moderna’s mRNA vaccine candidate has had a vaccine efficacy of 94.5%, the company announced today. unveiling the stunning, initial analysis of Phase 3 clinical trial results by an independent Data Safety Monitoring Board, appointed by the US National Institutes of Health. And news that the vaccine can be stored at 2° to 8°C (36° to […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Major New Clinical Trial Launched Across 13 African Countries To Test Treatments For Mild COVID-19 Cases 24/11/2020 Elaine Ruth Fletcher Thirteen African countries and an international network of research institutions have joined forces to launch a multi-country clinical trial of COVID-19 drug treatments in Africa for people who are mild to moderately ill. The new ANTICOV trial, led by the Geneva-based Drugs for Neglected Diseases Initiative (DNDi) aims to respond to the urgent need to […] Continue reading -> AstraZeneca Breakthrough Heightens Competition Between Two Different World Views On Vaccine Procurement & Distribution 23/11/2020 Elaine Ruth Fletcher, Menaka Rao & Kerry Cullinan The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading -> AstraZeneca’s COVID-19 Vaccine Candidate Can Prevent 90% Of Infections – Company Unveils Interim Results 23/11/2020 Madeleine Hoecklin & Elaine Ruth Fletcher AstraZeneca, the pharma firm developing a COVID-19 vaccine in collaboration with researchers at Oxford University, announced that its Phase 3 clinical trials had resulted in a 90% efficacy rate for one dosing regime, in interim results released on Monday. The AstraZeneca breakthrough is significant because the vaccine, based on a known vaccine delivery technology, is […] Continue reading -> Médecins Sans Frontières – Nearly 100 World Trade Organization Members Could Support “Waiver” On IP For COVID Health Technologies 19/11/2020 Elaine Ruth Fletcher Nearly 100 World Trade Organization member countries and entities could potentially swing behind a proposal by India and South Africa to enact a wide-ranging waiver of complex World Trade Organization requirements on the use of patented products, trade secrets and copyrights on health products during the pandemic, asserted the Médecins Sans Frontières (MSF) Access […] Continue reading -> Moderna’s COVID Vaccine Is 95% Effective – Independent NIH-Appointed Board Assessment – Higher Storage Temperature Make It Even Better News 16/11/2020 Elaine Ruth Fletcher Moderna’s mRNA vaccine candidate has had a vaccine efficacy of 94.5%, the company announced today. unveiling the stunning, initial analysis of Phase 3 clinical trial results by an independent Data Safety Monitoring Board, appointed by the US National Institutes of Health. And news that the vaccine can be stored at 2° to 8°C (36° to […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
AstraZeneca Breakthrough Heightens Competition Between Two Different World Views On Vaccine Procurement & Distribution 23/11/2020 Elaine Ruth Fletcher, Menaka Rao & Kerry Cullinan The vaccine zero hour is approaching. As Norway’s Minister of International Development Dag Ulstein and South Africa’s Minister of Health Zweili Mkhize made yet another urgent plea Monday for some US$4.3 billion right now and another $US23.9 billion in 2021 to massively roll out new COVID19 vaccines, drugs and tests that are now coming on […] Continue reading -> AstraZeneca’s COVID-19 Vaccine Candidate Can Prevent 90% Of Infections – Company Unveils Interim Results 23/11/2020 Madeleine Hoecklin & Elaine Ruth Fletcher AstraZeneca, the pharma firm developing a COVID-19 vaccine in collaboration with researchers at Oxford University, announced that its Phase 3 clinical trials had resulted in a 90% efficacy rate for one dosing regime, in interim results released on Monday. The AstraZeneca breakthrough is significant because the vaccine, based on a known vaccine delivery technology, is […] Continue reading -> Médecins Sans Frontières – Nearly 100 World Trade Organization Members Could Support “Waiver” On IP For COVID Health Technologies 19/11/2020 Elaine Ruth Fletcher Nearly 100 World Trade Organization member countries and entities could potentially swing behind a proposal by India and South Africa to enact a wide-ranging waiver of complex World Trade Organization requirements on the use of patented products, trade secrets and copyrights on health products during the pandemic, asserted the Médecins Sans Frontières (MSF) Access […] Continue reading -> Moderna’s COVID Vaccine Is 95% Effective – Independent NIH-Appointed Board Assessment – Higher Storage Temperature Make It Even Better News 16/11/2020 Elaine Ruth Fletcher Moderna’s mRNA vaccine candidate has had a vaccine efficacy of 94.5%, the company announced today. unveiling the stunning, initial analysis of Phase 3 clinical trial results by an independent Data Safety Monitoring Board, appointed by the US National Institutes of Health. And news that the vaccine can be stored at 2° to 8°C (36° to […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
AstraZeneca’s COVID-19 Vaccine Candidate Can Prevent 90% Of Infections – Company Unveils Interim Results 23/11/2020 Madeleine Hoecklin & Elaine Ruth Fletcher AstraZeneca, the pharma firm developing a COVID-19 vaccine in collaboration with researchers at Oxford University, announced that its Phase 3 clinical trials had resulted in a 90% efficacy rate for one dosing regime, in interim results released on Monday. The AstraZeneca breakthrough is significant because the vaccine, based on a known vaccine delivery technology, is […] Continue reading -> Médecins Sans Frontières – Nearly 100 World Trade Organization Members Could Support “Waiver” On IP For COVID Health Technologies 19/11/2020 Elaine Ruth Fletcher Nearly 100 World Trade Organization member countries and entities could potentially swing behind a proposal by India and South Africa to enact a wide-ranging waiver of complex World Trade Organization requirements on the use of patented products, trade secrets and copyrights on health products during the pandemic, asserted the Médecins Sans Frontières (MSF) Access […] Continue reading -> Moderna’s COVID Vaccine Is 95% Effective – Independent NIH-Appointed Board Assessment – Higher Storage Temperature Make It Even Better News 16/11/2020 Elaine Ruth Fletcher Moderna’s mRNA vaccine candidate has had a vaccine efficacy of 94.5%, the company announced today. unveiling the stunning, initial analysis of Phase 3 clinical trial results by an independent Data Safety Monitoring Board, appointed by the US National Institutes of Health. And news that the vaccine can be stored at 2° to 8°C (36° to […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Médecins Sans Frontières – Nearly 100 World Trade Organization Members Could Support “Waiver” On IP For COVID Health Technologies 19/11/2020 Elaine Ruth Fletcher Nearly 100 World Trade Organization member countries and entities could potentially swing behind a proposal by India and South Africa to enact a wide-ranging waiver of complex World Trade Organization requirements on the use of patented products, trade secrets and copyrights on health products during the pandemic, asserted the Médecins Sans Frontières (MSF) Access […] Continue reading -> Moderna’s COVID Vaccine Is 95% Effective – Independent NIH-Appointed Board Assessment – Higher Storage Temperature Make It Even Better News 16/11/2020 Elaine Ruth Fletcher Moderna’s mRNA vaccine candidate has had a vaccine efficacy of 94.5%, the company announced today. unveiling the stunning, initial analysis of Phase 3 clinical trial results by an independent Data Safety Monitoring Board, appointed by the US National Institutes of Health. And news that the vaccine can be stored at 2° to 8°C (36° to […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Moderna’s COVID Vaccine Is 95% Effective – Independent NIH-Appointed Board Assessment – Higher Storage Temperature Make It Even Better News 16/11/2020 Elaine Ruth Fletcher Moderna’s mRNA vaccine candidate has had a vaccine efficacy of 94.5%, the company announced today. unveiling the stunning, initial analysis of Phase 3 clinical trial results by an independent Data Safety Monitoring Board, appointed by the US National Institutes of Health. And news that the vaccine can be stored at 2° to 8°C (36° to […] Continue reading -> Posts navigation Older postsNewer posts